Today, the American Urological Association (AUA), in partnership with the American Society for Radiation Oncology (ASTRO), released the 2026 amendment to the Clinically Localized Prostate Cancer ...

A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...

Francis Medical, Inc., a privately held medical device company, today announced the continued expansion of its U.S.

The main advantage of proton therapy is its precision. Protons deposit most of their energy directly in the tumor with little ...

A 2026 informational overview of ProtoFlow's prostate support ingredients, formulation structure, and urinary wellness ...

From his perspective, one of the most persistent misconceptions in prostate cancer care relates to how patients interpret ...

ADT intensification may not improve prostate cancer survival. Explore real-world findings and key risk factors. Read more.

A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to ...

More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell ...

A common diabetes drug may mimic one key effect of exercise in prostate cancer patients. Researchers found metformin boosts an “exercise molecule” linked to appetite and weight control, even in those ...

Grant Learmont — 40-year-old from Dumfries, Scotland — was always an active dad of two. He played football, ran half ...

One survivor said it felt ‘as if the government are playing russian roulette’ with the lives of black men who are twice as ...